Mechanisms in the serotype-independent pneumococcal immunity induced in mice by intranasal vaccination with the cell wall polysaccharide

Tomasz, 1981, Surface components of Streptococcus pneumoniae, Rev Infect Dis, 3, 190, 10.1093/clinids/3.2.190 Fischer, 1993, Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide), Eur J Biochem, 215, 851, 10.1111/j.1432-1033.1993.tb18102.x Briles, 1981, Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae, J Exp Med., 153, 694, 10.1084/jem.153.3.694 Goldenberg, 2004, Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract, J Infect Dis, 190, 1254, 10.1086/424517 Wallick, 1983, Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate, J Immunol, 130, 2871, 10.4049/jimmunol.130.6.2871 Trolle, 2000, Intranasal immunization with protein-linked phosphorylcholine protects mice against a lethal intranasal challenge with Streptococcus pneumoniae, Vaccine, 18, 2991, 10.1016/S0264-410X(00)00089-X Szu, 1986, Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci, Infect Immun, 54, 448, 10.1128/IAI.54.2.448-455.1986 Musher, 1990, Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?, J Infect Dis, 161, 736, 10.1093/infdis/161.4.736 Nielsen, 1993, Antibodies against pneumococcal C-polysaccharide are not protective, Microb Pathog, 14, 299, 10.1006/mpat.1993.1029 Skov Sorensen, 1988, Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in pneumococci, Infect Immun, 56, 1890, 10.1128/IAI.56.8.1890-1896.1988 Malley, 2006, Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide, Infect Immun, 74, 2187, 10.1128/IAI.74.4.2187-2195.2006 Karlsson, 1999, The pneumococcal common antigen C-polysaccharide occurs in different forms. Mono-substituted or di-substituted with phosphocholine, Eur J Biochem, 265, 1091, 10.1046/j.1432-1327.1999.00835.x Skovsted, 2007, Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays, Vaccine, 25, 6490, 10.1016/j.vaccine.2007.06.034 Bergstrom, 2003, A unique variant of streptococcal group O-antigen (C-polysaccharide) that lacks phosphocholine, Eur J Biochem, 270, 2157, 10.1046/j.1432-1033.2003.03569.x Janeway, 2001 Chung, 2003, CD4+T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism, J Immunol, 170, 1958, 10.4049/jimmunol.170.4.1958 Kalka-Moll, 2000, Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity, J Immunol, 164, 719, 10.4049/jimmunol.164.2.719 Malley, 2001, Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci, Infect Immun, 69, 4870, 10.1128/IAI.69.8.4870-4873.2001 Lu, 2008, Interleukin-17A mediates acquired immunity to pneumococcal colonization, PLoS Pathog, 4, e1000159, 10.1371/journal.ppat.1000159 Cobb, 2004, Polysaccharide processing and presentation by the MHCII pathway, Cell, 117, 677, 10.1016/j.cell.2004.05.001 Austrian, 1986, Some aspects of the pneumococcal carrier state, J Antimicrob Chemother A, 18, 35, 10.1093/jac/18.Supplement_A.35 Kim, 1998, Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae, J Infect Dis, 177, 368, 10.1086/514205 van Rossum, 2005, Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model, Infect Immun, 73, 7718, 10.1128/IAI.73.11.7718-7726.2005 Weiser, 1998, Phase variation in colony opacity by Streptococcus pneumoniae, Microb Drug Resist, 4, 129, 10.1089/mdr.1998.4.129 Cundell, 1995, Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor, Nature, 377, 435, 10.1038/377435a0 Kadioglu, 2004, CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection, Infect Immun, 72, 2689, 10.1128/IAI.72.5.2689-2697.2004 McCool, 2004, Limited role of antibody in clearance of Streptococcus pneumoniae in a Murine model of colonization, Infect Immun, 72, 5807, 10.1128/IAI.72.10.5807-5813.2004 Malley, 2005, CD4+T cells mediate antibody-independent acquired immunity to pneumococcal colonization, Proc Natl Acad Sci USA, 102, 4848, 10.1073/pnas.0501254102 Trzcinski, 2005, Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model, Infect Immun, 73, 7043, 10.1128/IAI.73.10.7043-7046.2005 Basset, 2007, Antibody-independent, CD4+T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins, Infect Immun, 75, 5460, 10.1128/IAI.00773-07 Briles, 2000, Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae, Infect Immun, 68, 796, 10.1128/IAI.68.2.796-800.2000 Lu, 2009, Protection against pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide, Infect Immun, 77, 2076, 10.1128/IAI.01554-08 Granat, 2009, Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage, J Infect Dis, 200, 99, 10.1086/599364 Zhang, 2009, Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice, J Clin Invest, 10.1172/JCI36731 Lees, 1996, Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein- polysaccharide conjugate vaccines and immunological reagents, Vaccine, 14, 190, 10.1016/0264-410X(95)00195-7 Roe, 1955, The determination of sugar in blood and spinal fluid with anthrone reagent, J Biol Chem, 212, 335, 10.1016/S0021-9258(18)71120-4 Park, 1949, A submicrodetermination of glucose, J Biol Chem, 181, 149, 10.1016/S0021-9258(18)56635-7